SymBio Pharmaceuticals Limited (4582.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
SymBio Pharmaceuticals Limited
Address
Toranomon Towers Office
Tokyo, 105-0001
Japan
Phone
81 3 5472 1125
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
91
First IPO Date
October 20, 2011
Key Executives
| Name | Title | Pay | Year Born |
| Fuminori Yoshida | Chief Executive Officer, President & Representative Director | 0 | 1949 |
| Edwin Rock | Corporate Officer, Corporate VP and Head of Global R&D Division | 0 | 1962 |
| Masahiko Okuno | Corporate Officer | 0 | N/A |
| Minori Rosales | Corporate Officer, CMO Oncology & Neurology and Head of Japan Development Division | 0 | 1963 |
| Hiroyuki Horita | Corporate Officer | 0 | N/A |
| Yoshiharu Torikai | Corporate Officer | 0 | N/A |
| Tomonori Seta | Corporate Officer | 0 | N/A |
AD
Description
SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan.
AD
